- Home
- DNTH vs TPB Comparison
DNTH vs TPB Comparison
Compare DNTH & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- TPB
- Stock Information
- Founded
- DNTH 2015
- TPB 1988
- Country
- DNTH United States
- TPB United States
- Employees
- DNTH N/A
- TPB N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- TPB Tobacco
- Sector
- DNTH Health Care
- TPB Consumer Discretionary
- Exchange
- DNTH Nasdaq
- TPB Nasdaq
- Market Cap
- DNTH 1.4B
- TPB 1.6B
- IPO Year
- DNTH N/A
- TPB 2016
- Fundamental
- Price
- DNTH $33.73
- TPB $101.16
- Analyst Decision
- DNTH Strong Buy
- TPB Strong Buy
- Analyst Count
- DNTH 11
- TPB 5
- Target Price
- DNTH $65.22
- TPB $77.00
- AVG Volume (30 Days)
- DNTH 503.3K
- TPB 435.4K
- Earning Date
- DNTH 11-05-2025
- TPB 11-05-2025
- Dividend Yield
- DNTH N/A
- TPB 0.30%
- EPS Growth
- DNTH N/A
- TPB N/A
- EPS
- DNTH N/A
- TPB 0.19
- Revenue
- DNTH $4,854,000.00
- TPB $421,603,000.00
- Revenue This Year
- DNTH N/A
- TPB $24.45
- Revenue Next Year
- DNTH N/A
- TPB $8.46
- P/E Ratio
- DNTH N/A
- TPB $520.46
- Revenue Growth
- DNTH 17.87
- TPB 39.93
- 52 Week Low
- DNTH $13.37
- TPB $47.53
- 52 Week High
- DNTH $40.16
- TPB $110.55
- Technical
- Relative Strength Index (RSI)
- DNTH 47.36
- TPB 67.70
- Support Level
- DNTH $32.28
- TPB $88.88
- Resistance Level
- DNTH $35.40
- TPB $90.84
- Average True Range (ATR)
- DNTH 1.62
- TPB 4.97
- MACD
- DNTH -0.20
- TPB 1.39
- Stochastic Oscillator
- DNTH 27.78
- TPB 66.30
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.